lumbar spinal stenosis. Spinal stenosis, lumbar region
Conditions
Interventions
Intervention 1: Intervention group 1: intramuscular paravertebral injection of oxygen –ozone with 10 microgram/cc - 3 times at week for 5 weeks. Intervention 2: Intervention group 2: high intensity la
dose 100 J / cm². 5 15-minute sessions per week for 2 weeks. Intervention 3: Control group: Exercises included lower trunk rotation
knee to chest
pelvic tilt, which strengthens and stabilizes the muscles of the abdomen, back and pelvis. All treatment groups were instructed to exercise three times a day for 2 weeks.
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: Informed consent to participate in the study Existence of neurological pain and lameness in the last six months Age between 35-75 years Absence of any spinal or musculoskeletal disease No response to drug treatment for more than 3 months
Exclusion criteria
Exclusion criteria: Diabetes mellitus Body mass index more than 41 History of fracture of the spine History of bleeding disorders Rheumatic diseases Neuropathy Psychological diseases Brucellosis Genetic diseases such as galactose intolerance or lactase deficiency Congenital heart diseases Allergic reactions to bovine proteins Inability to communicate History of significant liver, kidney and heart disorders Injections in or around the affected joint in the last six months Pregnancy Cancer People who are taking anticoagulants People with Favism Vascular claudication History of previous spinal surgery Indication of emergency surgery Any ban on ozone treatment Any ban on acetaminophen People consuming codeine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before treatment, immediately after treatment, and at weeks 4 and 8 after treatment. Method of measurement: Somatic symptom scale questionnaire.;Physical activity. Timepoint: Before treatment, immediately after treatment, and at weeks 4 and 8 after treatment. Method of measurement: Somatic symptom scale questionnaire.;Satisfaction. Timepoint: Before treatment, immediately after treatment, and at weeks 4 and 8 after treatment. Method of measurement: Somatic symptom scale questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSamira Shahabi Rabori
Yazd University of Medical Sciences
Outcome results
None listed